In this session, Professor Bob Khanna explores how the BeVigilant™ OraFusion™ system can support earlier identification of oral cancer risk using chairside saliva-based biomarker testing. The webinar focuses on real clinical application – demonstrating how OraFusion can be incorporated into everyday dental appointments to provide an objective risk assessment in around 15 minutes.
By combining key biomarkers with individual patient risk factors, the system helps clinicians move beyond visual assessment alone when faced with uncertainty. Alongside the clinical insight, the session also covers the practical considerations of introducing structured oral cancer screening into a modern dental practice – including how it can fit within the patient journey and support the development of additional clinical services.
Discover BeVigilant™ OraFusion™
